Bunitrolol

Bunitrolol is a beta-adrenergic antagonist.[1]

Bunitrolol
Names
IUPAC name
2-[3-(tert-Butylamino)-2-hydroxypropoxy]benzonitrile
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
UNII
  • InChI=1S/C14H20N2O2/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15/h4-7,12,16-17H,9-10H2,1-3H3
    Key: VCVQSRCYSKKPBA-UHFFFAOYSA-N
  • InChI=1/C14H20N2O2/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15/h4-7,12,16-17H,9-10H2,1-3H3
    Key: VCVQSRCYSKKPBA-UHFFFAOYAU
  • CC(C)(C)NCC(COC1=CC=CC=C1C#N)O
Properties
C14H20N2O2
Molar mass 248.326 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Synthesis

Made from 2-Hydroxybenzonitrile [611-20-1] (1) by treatment with epichlorohydrin in lye to give 2-glycidyloxybenzonitrile [38465-16-6] (2). Addition of tert-butylamine completed the synthesis of bunitrolol (3).

See also

References
  1. Haddad, S; Poulin, P; Funk, C (2010). "Extrapolating in vitro metabolic interactions to isolated perfused liver: Predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine". Journal of Pharmaceutical Sciences. 99 (10): 4406–26. doi:10.1002/jps.22136. PMID 20310018.
  2. Herbert Koppe, Albrecht Engelhardt, Karl Zeile, U.S. patent 3,940,489 (1976 to Boehringer Ingelheim Gmbh).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.